- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Medium dose of BIIL 284 BS tablets
Total 1114 results
-
Royal Perth HospitalRecruitingObesity | Type 2 Diabetes Mellitus | Metabolic SyndromeAustralia
-
Ranbaxy Laboratories LimitedCompleted
-
Actavis Inc.Completed
-
Actavis Inc.CompletedHealthyUnited States
-
Actavis Inc.Completed
-
Laboratório Teuto Brasileiro S/AUnknown
-
Mylan Pharmaceuticals IncCompleted
-
Teva Pharmaceuticals USACompleted
-
Actavis Inc.Completed
-
Miulli General HospitalNot yet recruitingHeart Failure | Obesity | Diabetes Mellitus | Atrial FibrillationItaly
-
Oslo University HospitalRecruitingCentral Retinal Artery OcclusionDenmark, Norway, Belgium, Sweden, Finland, Ireland, Lithuania, Australia, Austria
-
Teva Pharmaceuticals USACompleted
-
Larissa University HospitalTerminatedAcute Decompensated Heart FailureUnited States, Greece
-
Helixmith Co., Ltd.UnknownIschemic Heart Disease | Acute Myocardial InfarctionKorea, Republic of
-
The Affiliated Hospital of Qingdao UniversityRecruitingHealthy VolunteersChina
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
SandozCompleted
-
TakedaCompleted
-
University of SydneyNorthern Care Alliance NHS Foundation Trust; Waitemata District Health Board; Australasian Kidney Trials NetworkRecruiting
-
University of LeicesterAstraZeneca; Royal Surrey County Hospital NHS Foundation TrustCompletedThe Effect of a SGLT2 Inhibitor on Glucose Flux, Lipolysis and Exercise in Type 2 Diabetes (SINGLED)Type 2 DiabetesUnited Kingdom
-
Actavis Inc.CompletedHealthyUnited States
-
Actavis Inc.CompletedHealthyUnited States
-
Teva Pharmaceuticals USACompleted
-
LM Diagnósticos S.L.AstraZenecaUnknown
-
Boehringer IngelheimCompleted
-
Xuanwu Hospital, BeijingCompletedCerebral Angiography | HeparinizationChina
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
Dexa Medica GroupCompleted
-
SandozCompleted
-
Kobe UniversityBoehringer IngelheimActive, not recruitingInsulin Resistance - Type A | Insulin Resistance - Type B | Lipoatrophic Diabetes Mellitus | Insulin Resistance SyndromeJapan
-
Boehringer IngelheimCompleted
-
University Health Network, TorontoRecruitingType 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes MellitusCanada
-
Yaounde Central HospitalCompleted
-
Actavis Inc.Completed
-
UCB BIOSCIENCES, Inc.PRA Health SciencesTerminatedNonconvulsive Electrographic SeizuresUnited States
-
Boehringer IngelheimCompleted
-
Eisai Inc.CompletedPartial Onset SeizuresFrance, United Kingdom, Germany, Denmark, Czech Republic, Norway, Sweden, Ireland
-
Henrik WiggersDanish Heart Foundation; Danish Council for Independent Research; The Danish... and other collaboratorsRecruiting
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Sinovac Research and Development Co., Ltd.Completed
-
BiogenCompleted
-
Shanghai Zhongshan HospitalActive, not recruiting
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Preserved Systolic FunctionUnited States